Themis Medicare (Themis) has entered into a Supply & Distribution Agreement with Novartis India (Novartis) on August 16, 2013. As per agreement, Themis has agreed to manufacture and supply and Novartis has agreed long term exclusive purchase from Themis Diclofenac Sodium 75 mg per ml Injection as finished dosage pharmaceutical form on certain commercial terms and conditions for Indian market.
Themis Medicare is also engaged in supplying its research formulations to well known Pharmaceutical companies in India namely Alkem Lab, Fulford, Intas Pharmaceuticals, IPCA Lab., Cadila Healthcare, Aristo Pharma, Mankind Pharma, Shreya Lifesciences, Nicholas Piramal, Unichem Lab, etc.
